-
公开(公告)号:US09029115B2
公开(公告)日:2015-05-12
申请号:US13587043
申请日:2012-08-16
申请人: Allan Svendsen , Michael Skjoet , Deborah Yaver , Lars Lehmann Hylling Christensen , Signe Eskildsen Larsen , Nina Lundin , Michael Lamsa , Peter Colin Gregory
发明人: Allan Svendsen , Michael Skjoet , Deborah Yaver , Lars Lehmann Hylling Christensen , Signe Eskildsen Larsen , Nina Lundin , Michael Lamsa , Peter Colin Gregory
CPC分类号: A61K38/465 , A61K38/47 , A61K38/48 , C12N9/20
摘要: The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The lipases of the invention have, e.g., an improved digestion performance in vitro, an improved activity at a pH in the neutral range, an improved stability at low pH, and are stable against protease-degradation, and/or are stable in the presence of pepsin and bile salts. The invention also relates to methods of determining digestion performance in vitro of lipases, as well as to certain novel variants of the lipase of T. lanuginosus.
摘要翻译: 与包含SEQ ID NO:2的氨基酸1-269的Thermomyces lanuginosus(Humicola lanuginosa)脂肪酶相关的脂肪酶的药物用途,任选地与蛋白酶和/或淀粉酶组合。 医学适应症的例子有:消化系统疾病,胰腺外分泌功能不全(PEI),胰腺炎,囊性纤维化,I型糖尿病和/或II型糖尿病的治疗。 本发明的脂肪酶例如在体外具有改善的消化性能,在中性范围内的pH值改善的活性,在低pH下的改进的稳定性,并且对蛋白酶降解是稳定的,和/或在存在下是稳定的 的胃蛋白酶和胆汁盐。 本发明还涉及确定脂肪酶的体外消化性能的方法以及T.lanuginosus的脂肪酶的某些新颖变体。
-
公开(公告)号:US20120308543A1
公开(公告)日:2012-12-06
申请号:US13587043
申请日:2012-08-16
申请人: Allan Svendsen , Michael Skjoet , Deborah Yaver , Lars Lehmann Hylling Christensen , Signe Eskildsen Larsen , Nina Lundin , Michael Lamsa , Peter Colin Gregory
发明人: Allan Svendsen , Michael Skjoet , Deborah Yaver , Lars Lehmann Hylling Christensen , Signe Eskildsen Larsen , Nina Lundin , Michael Lamsa , Peter Colin Gregory
CPC分类号: A61K38/465 , A61K38/47 , A61K38/48 , C12N9/20
摘要: The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The lipases of the invention have, e.g., an improved digestion performance in vitro, an improved activity at a pH in the neutral range, an improved stability at low pH, an are stable against protease-degradation, and/or are stable in the presence of pepsin and bile salts. The invention also relates to methods of determining digestion performance in vitro of lipases, as well as to certain novel variants of the lipase of T. lanuginosus.
摘要翻译: 与包含SEQ ID NO:2的氨基酸1-269的Thermomyces lanuginosus(Humicola lanuginosa)脂肪酶相关的脂肪酶的药物用途,任选地与蛋白酶和/或淀粉酶组合。 医学适应症的例子有:消化系统疾病,胰腺外分泌功能不全(PEI),胰腺炎,囊性纤维化,I型糖尿病和/或II型糖尿病的治疗。 本发明的脂肪酶具有例如体外改进的消化性能,在中性范围内的pH值改善的活性,在低pH下的改进的稳定性,对蛋白酶降解是稳定的,和/或在存在时是稳定的 的胃蛋白酶和胆汁盐。 本发明还涉及确定脂肪酶的体外消化性能的方法以及T.lanuginosus的脂肪酶的某些新颖变体。
-
公开(公告)号:US08273348B2
公开(公告)日:2012-09-25
申请号:US12519868
申请日:2007-12-12
申请人: Allan Svendsen , Michael Skjoet , Debbie Yaver , Lars Lehmann Hylling Christensen , Signe Eskildsen Larsen , Nina Lundin , Michael Lamsa , Peter Colin Gregory
发明人: Allan Svendsen , Michael Skjoet , Debbie Yaver , Lars Lehmann Hylling Christensen , Signe Eskildsen Larsen , Nina Lundin , Michael Lamsa , Peter Colin Gregory
IPC分类号: A61K38/54 , A61K38/46 , C12Q1/34 , C12Q1/40 , C12N9/20 , C12N9/14 , C12N9/26 , C07H21/04 , C07K1/00
CPC分类号: A61K38/465 , A61K38/47 , A61K38/48 , C12N9/20
摘要: The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The lipases of the invention have, e.g., an improved digestion performance in vitro, an improved activity at a pH in the neutral range, an improved stability at low pH, an are stable against protease-degradation, and/or are stable in the presence of pepsin and bile salts. The invention also relates to methods of determining digestion performance in vitro of lipases, as well as to certain novel variants of the lipase of T. lanuginosus.
摘要翻译: 与包含SEQ ID NO:2的氨基酸1-269的Thermomyces lanuginosus(Humicola lanuginosa)脂肪酶相关的脂肪酶的药物用途,任选地与蛋白酶和/或淀粉酶组合。 医学适应症的例子有:消化系统疾病,胰腺外分泌功能不全(PEI),胰腺炎,囊性纤维化,I型糖尿病和/或II型糖尿病的治疗。 本发明的脂肪酶具有例如体外改进的消化性能,在中性范围内的pH值改善的活性,在低pH下的改进的稳定性,对蛋白酶降解是稳定的,和/或在存在时是稳定的 的胃蛋白酶和胆汁盐。 本发明还涉及确定脂肪酶的体外消化性能的方法以及T.lanuginosus的脂肪酶的某些新颖变体。
-
公开(公告)号:US20090203106A1
公开(公告)日:2009-08-13
申请号:US12420446
申请日:2009-04-08
申请人: Leonardo De Maria , Allan Svendsen , Torben Vedel Borchert , Lars Lehmann Hylling Christensen , Carsten Ryttergaard , Sine Larsen
发明人: Leonardo De Maria , Allan Svendsen , Torben Vedel Borchert , Lars Lehmann Hylling Christensen , Carsten Ryttergaard , Sine Larsen
IPC分类号: C12N9/24
CPC分类号: C12N9/2468 , C12Y302/01089
摘要: The present invention relates to variants of Glycoside Hydrolase family 53 galactanases, e.g., variants of the galactanases from strains of Yersinia, Aspergillus, Humicola, Meripilus, Myceliophthora, Thermomyces, Bacillus, Bifidobacterium, Cellvibrio, Clostridium, Pseudomonas, Thermotoga, or Xanthomonas.
摘要翻译: 本发明涉及糖苷水解酶家族53半乳聚糖酶的变体,例如来自耶尔森氏菌,曲霉属,腐质霉属,Meripilus,Myceliophthora,Thermomyces,Bacillus,Bifidobacterium,Cellvibrio,Clostridium,Pseudomonas,Thermotoga或黄单胞菌属的半乳聚糖酶的变体。
-
公开(公告)号:US08367390B2
公开(公告)日:2013-02-05
申请号:US12420446
申请日:2009-04-08
申请人: Leonardo De Maria , Allan Svendsen , Torben Vedel Borchert , Lars Lehmann Hylling Christensen , Sine Larsen , Carsten Ryttersgaard
发明人: Leonardo De Maria , Allan Svendsen , Torben Vedel Borchert , Lars Lehmann Hylling Christensen , Sine Larsen , Carsten Ryttersgaard
CPC分类号: C12N9/2468 , C12Y302/01089
摘要: The present invention relates to variants of Glycoside Hydrolase family 53 galactanases, e.g., variants of the galactanases from strains of Yersinia, Aspergillus, Humicola, Meripilus, Myceliophthora, Thermomyces, Bacillus, Bifidobacterium, Cellvibrio, Clostridium, Pseudomonas, Thermotoga, or Xanthomonas.
摘要翻译: 本发明涉及糖苷水解酶家族53半乳聚糖酶的变体,例如来自耶尔森氏菌,曲霉属,腐质霉属,Meripilus,Myceliophthora,Thermomyces,Bacillus,Bifidobacterium,Cellvibrio,Clostridium,Pseudomonas,Thermotoga或黄单胞菌属的半乳聚糖酶的变体。
-
公开(公告)号:US07537921B2
公开(公告)日:2009-05-26
申请号:US10537746
申请日:2003-12-11
申请人: Leonardo De Maria , Allan Svendsen , Torben Vedel Borchert , Lars Lehmann Hylling Christensen , Sine Larsen , Carsten Ryttersgaard
发明人: Leonardo De Maria , Allan Svendsen , Torben Vedel Borchert , Lars Lehmann Hylling Christensen , Sine Larsen , Carsten Ryttersgaard
CPC分类号: C12N9/2468 , C12Y302/01089
摘要: Variants of Glycoside Hydrolase family 53 galactanases, e.g. variants of the galactanases from strains of Yersinia, Aspergillus, Humicola, Meripilus, Myceliophthora, Thermomyces, Bacillus, Bifidobacterium, Cellvibrio, Clostridium, Pseudomonas, Thermotoga, or Xanthomonas.
摘要翻译: 糖苷类水解酶家族53半乳聚糖酶的变体,例如 来自耶尔森氏菌属,曲霉属,腐质霉属,Meripilus,Myceliophthora,Thermomyces,Bacillus,Bifidobacterium,Cellvibrio,Clostridium,Pseudomonas,Thermotoga或Xanthomonas的菌株的半乳聚糖酶的变体。
-
公开(公告)号:US20110097445A1
公开(公告)日:2011-04-28
申请号:US12984826
申请日:2011-01-05
申请人: Leonardo De Maria , Carsten Andersen , Lars Lehmann Hylling Christensen , Søren Flensted Lassen , Peter Rahbek Østergaard
发明人: Leonardo De Maria , Carsten Andersen , Lars Lehmann Hylling Christensen , Søren Flensted Lassen , Peter Rahbek Østergaard
CPC分类号: C12N9/58 , A01K2217/05 , A23K20/189 , C12N9/48 , C12N9/52 , C12N2310/111
摘要: The invention relates to a novel 3D structure encoding a Nocardiopsis protease, as well as to variants of parent protease homologous to Nocardiopsis proteases, preferably of improved thermostability and/or with an amended temperature activity profile. The invention also relates to DNA sequences encoding such variants, their production in a recombinant host cell, as well as methods of using the variants, in particular within the field of animal feed and detergents. The invention furthermore relates to methods of generating and preparing protease variants of amended properties.
摘要翻译: 本发明涉及编码诺卡氏菌蛋白酶的新型3D结构,以及与诺卡氏菌蛋白酶同源的亲本蛋白酶的变体,优选具有改善的热稳定性和/或具有修改的温度活性分布。 本发明还涉及编码这些变体的DNA序列,其在重组宿主细胞中的产生,以及使用该变体,特别是在动物饲料和洗涤剂领域中的方法。 本发明还涉及生成和制备修饰性质的蛋白酶变体的方法。
-
公开(公告)号:US20120009300A1
公开(公告)日:2012-01-12
申请号:US13242491
申请日:2011-09-23
IPC分类号: C12N9/42 , C12N15/63 , C12N1/21 , C12N5/10 , B32B5/16 , C12N1/19 , A01H5/00 , A23J3/34 , A21D8/04 , C12N15/56 , C12N1/15
CPC分类号: A21D2/24 , A21D8/042 , Y10T428/2982
摘要: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
摘要翻译: 本发明涉及抗陈酿GH-61多肽用于制备食用产品的用途。
-
公开(公告)号:US07803590B2
公开(公告)日:2010-09-28
申请号:US12616921
申请日:2009-11-12
CPC分类号: A21D2/24 , A21D8/042 , Y10T428/2982
摘要: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
摘要翻译: 本发明涉及抗陈酿GH-61多肽用于制备食用产品的用途。
-
公开(公告)号:US07273738B2
公开(公告)日:2007-09-25
申请号:US10676902
申请日:2003-10-01
CPC分类号: A21D2/24 , A21D8/042 , Y10T428/2982
摘要: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
摘要翻译: 本发明涉及抗陈酿GH-61多肽用于制备食用产品的用途。
-
-
-
-
-
-
-
-
-